Literature DB >> 25416821

Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future.

Rutger J Maas1, Jeroen K Deegens1, Jack F Wetzels1.   

Abstract

The term idiopathic nephrotic syndrome (iNS) traditionally covers minimal change disease and primary focal segmental glomerulosclerosis (FSGS), now thought to be separate disease entities. Clinical and experimental evidence suggest that circulating permeability factors are involved in their pathogenesis. In the past four decades, many investigators have searched for the responsible factors, thus far with little success. The recent report of the soluble urokinase plasminogen activator receptor as a causative factor in FSGS has received much attention, but again the initially promising findings were not confirmed. We describe the history of the search for permeability factors, discuss the pitfalls that are likely responsible for the lack of success and propose criteria that should be used in future studies when evaluating candidate permeability factors.
© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  focal segmental glomerulosclerosis; idiopathic nephrotic syndrome; minimal change disease; permeability factor; suPAR

Mesh:

Substances:

Year:  2014        PMID: 25416821     DOI: 10.1093/ndt/gfu355

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  34 in total

Review 1.  Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.

Authors:  Kirk N Campbell; James A Tumlin
Journal:  Am J Nephrol       Date:  2018-05-31       Impact factor: 3.754

2.  Therapy: Maintenance of steroid-free remission in nephrotic syndrome.

Authors:  Jeroen K Deegens; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2015-07-21       Impact factor: 28.314

3.  On the Origin of Urinary Renin: A Translational Approach.

Authors:  Lodi C W Roksnoer; Bart F J Heijnen; Daisuke Nakano; Janos Peti-Peterdi; Stephen B Walsh; Ingrid M Garrelds; Jeanette M G van Gool; Robert Zietse; Harry A J Struijker-Boudier; Ewout J Hoorn; A H Jan Danser
Journal:  Hypertension       Date:  2016-02-29       Impact factor: 10.190

Review 4.  Focal segmental glomerular sclerosis: do not overlook the role of immune response.

Authors:  Francesco Reggiani; Claudio Ponticelli
Journal:  J Nephrol       Date:  2016-02-20       Impact factor: 3.902

Review 5.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

Review 6.  Genetics of childhood steroid-sensitive nephrotic syndrome.

Authors:  Alana M Karp; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2016-07-29       Impact factor: 3.714

7.  HDL and Kidney Diseases.

Authors:  Huanhuan Cao; Xia Meng
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 8.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

Review 9.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

10.  Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases.

Authors:  Panagiotis Garantziotis; Stavros A P Doumas; Ioannis Boletis; Eleni Frangou
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.